Headache Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial (S52.008)

Conclusions:Our findings provide class I evidence that CSF pressure and headaches are independent features of IIH.Study Supported by: National Eye Institute (1U10EY017281-01A1, DCBC 1U10EY017387-01A1, ARRA for NORDIC 3U10EY017281-01A1S1, and DCBC 1U10EY017387-01A1S1, and supplements for NORDIC 3U10EY017281-01A1S2)Disclosure: Dr. Friedman has received personal compensation for activities with Allergan, Teva, Eli Lilly, Avenir, Zosano, Amgen, Alder, Supernus and Trigemina as a speaker or advisory board member. Dr. Mejico has nothing to disclose. Dr. Subramanian has nothing to disclose. Dr. Quiros has nothing to disclose. Dr. McDermott has nothing to disclose.

Source: Neurology - April 17, 2017 Category: Neurology Authors: Friedman, D., Mejico, L., Subramanian, P., Quiros, P., McDermott, M. Tags: Headache: Clinical Trials and Disease Burden Source Type: research